Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

2026 data Public-data reference. official source

Social Anxiety Disorder

Open-data reference.

33 US clinical trials · 18 currently recruiting

Active & Recent Trials

RECRUITING NA 600 participants

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

University of Texas at Austin

NCT05467683

RECRUITING Phase 3 308 participants

P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety

Otsuka Pharmaceutical Development & Commercialization

NCT06973577

RECRUITING NA 264 participants

Comparing TBT to Disorder-Specific Psychotherapy in Veterans With Social Anxiety Disorder

VA Office of Research and Development

NCT05858346

RECRUITING NA 256 participants

Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity

University of Minnesota

NCT05117255

RECRUITING NA 240 participants

Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety

Boston University Charles River Campus

NCT05683223

RECRUITING NA 200 participants

Group Exposure Workshops for Socially Anxious Undergraduates

University of Colorado, Boulder

NCT06673407

RECRUITING NA 180 participants

Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety

University of Texas at Austin

NCT05427708

RECRUITING NA 160 participants

Individual Factors of CBT Underlying Success

University of Washington

NCT06678295

RECRUITING NA 139 participants

Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

Baylor College of Medicine

NCT06537128

RECRUITING NA 110 participants

Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4

University of Michigan

NCT06563310

RECRUITING NA 80 participants

Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth

Children's Hospital Los Angeles

NCT06526260

RECRUITING NA 80 participants

Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method

Georgetown University

NCT07028216

RECRUITING Phase 2 60 participants

A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder

VistaGen Therapeutics

NCT06809179

RECRUITING NA 60 participants

Targeting Social Function in Anxiety and Eating Disorders

University of Texas Southwestern Medical Center

NCT06198023

RECRUITING NA 60 participants

Attention Bias Modification Training for Social Phobia (ABMSP)

University of Wisconsin, Milwaukee

NCT06054386

RECRUITING NA 40 participants

Using TMS to Understand Neural Processes of Social Motivation

Auburn University

NCT06274112

RECRUITING NA 40 participants

Application of Virtual Reality Technology to Treatment of Social Anxiety

The University of Texas Health Science Center, Houston

NCT06845488

RECRUITING NA 40 participants

Mindful Self-Compassion for Anxiety Disorders and Depression

Georgetown University

NCT05671419

ACTIVE NOT RECRUITING Phase 3 238 participants

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)

VistaGen Therapeutics

NCT06358651

COMPLETED NA 559 participants

Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

Mclean Hospital

NCT02305537

COMPLETED Phase 3 370 participants

Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1

Bionomics Limited

NCT06510504

COMPLETED Phase 2 239 participants

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

EmpowerPharm

NCT05600114

COMPLETED NA 150 participants

Effects of Therapeutic Mobile Game on Anxiety

Hunter College of City University of New York

NCT05240794

COMPLETED Phase 3 150 participants

Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder

Temple University

NCT00074802

COMPLETED NA 97 participants

Virtual Reality Exposure Therapy for the Treatment of Social Phobia

Georgia State University

NCT02379949

COMPLETED NA 65 participants

Computerized Treatment for Social Anxiety

Florida State University

NCT03101553

COMPLETED Phase 1 60 participants

Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder

Stefan G. Hofmann

NCT01856530

COMPLETED Phase 2 60 participants

Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

NYU Langone Health

NCT05571592

COMPLETED Phase 4 50 participants

Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder

Emory University

NCT00208741

COMPLETED NA 45 participants

Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli

Georgetown University

NCT03206437

COMPLETED NA 44 participants

Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia

Penn State University

NCT04850989

COMPLETED Phase 4 40 participants

Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults

Cambridge Health Alliance

NCT01224067

COMPLETED Phase 3 40 participants

Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety

Southern Methodist University

NCT00958880

Phase Distribution

PhaseTrial count
Early Phase 1 1
Phase 2 3
Phase 3 5
Phase 4 2

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Social Anxiety Disorder Trial Landscape

ClinicalTrials.gov lists 33 US studies indexed under Social Anxiety Disorder, and 18 of those are currently open to recruitment — roughly 55% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Social Anxiety Disorder shows 7 late-stage studies (Phase 3 and Phase 4 combined) alongside 4 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Social Anxiety Disorder is led by Georgetown University with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 33 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Social Anxiety Disorder?

PlainTrial tracks 33 US clinical trials for Social Anxiety Disorder, of which 18 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Social Anxiety Disorder?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →